![Christopher Clinton Conway: Los Angeles now offers the only FDA-cleared safe, noninvasive quantitative transmission ultrasound in the QT Imaging Breast Center, Los Angeles at Beverly Hills, A Project of the Dr. Susan Love Foundation.](https://oncodaily.com/pub/uploads/2023/08/Christopher-Clinton-1-e1693432379882-1280x909.jpg)
Christopher Clinton Conway: Los Angeles now offers the only FDA-cleared safe, noninvasive quantitative transmission ultrasound in the QT Imaging Breast Center, Los Angeles at Beverly Hills, A Project of the Dr. Susan Love Foundation.
According to Christopher Clinton Conway, CEO of Dr. Susan Love Foundation for Breast Cancer Research, on LinkedIn:
“Los Angeles now offers the only FDA-cleared safe, noninvasive quantitative transmission ultrasound in the QT Imaging Breast Center, Los Angeles at Beverly Hills, A Project of the Dr. Susan Love Foundation. The breakthrough innovation offers a no radiation, non-compression 3D image of the breast to complement traditional mammography and provide added crucial visualization and data including ductal networks.
The first in class imaging center, a collaboration between the Dr. Susan Love Foundation for Breast Cancer Research and QT Ultrasound LLC is open at 145 Robertson Boulevard in Beverly Hills. Appointments are necessary. The procedure is $399 and includes the breast scan appointment, and a detailed image report reading by a radiologist.”
For details click here.
Source: Christopher Clinton Conway/LinkedIn
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023